{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T11:40:25Z","timestamp":1771328425660,"version":"3.50.1"},"publisher-location":"Cham","reference-count":138,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319588094","type":"print"},{"value":"9783319588117","type":"electronic"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-3-319-58811-7_11","type":"book-chapter","created":{"date-parts":[[2017,9,27]],"date-time":"2017-09-27T14:48:09Z","timestamp":1506523689000},"page":"285-304","source":"Crossref","is-referenced-by-count":17,"title":["Role of Phosphodiesterases in Huntington\u2019s Disease"],"prefix":"10.1007","author":[{"given":"Francesca R.","family":"Fusco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuela","family":"Paldino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,28]]},"reference":[{"key":"11_CR1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0166-2236(95)93943-R","volume":"18","author":"RL Albin","year":"1995","unstructured":"Albin RL, Tagle DA. Genetics and molecular biology of Huntington\u2019s disease. Trends Neurosci. 1995;18:11\u20134.","journal-title":"Trends Neurosci"},{"key":"11_CR2","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/39885","volume":"389","author":"CA Altar","year":"1997","unstructured":"Altar CA, Cai N, Bliven T, Juhasz M, Conner JM, Acheson AL, et al. Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature. 1997;389:856\u201360.","journal-title":"Nature"},{"key":"11_CR3","doi-asserted-by":"crossref","first-page":"9930","DOI":"10.1523\/JNEUROSCI.21-24-09930.2001","volume":"21","author":"M Andersson","year":"2001","unstructured":"Andersson M, Konradi C, Cenci MA. cAMP response element-binding protein is required for dopamine-dependent gene expression in the intact but not the dopamine-denervated striatum. J Neurosci. 2001;21:9930\u201343.","journal-title":"J Neurosci"},{"key":"11_CR4","doi-asserted-by":"crossref","first-page":"9068","DOI":"10.1523\/JNEUROSCI.21-22-09068.2001","volume":"21","author":"SG Andreeva","year":"2001","unstructured":"Andreeva SG, Dikkes P, Epstein PM, Rosenberg PA. Expression of cGMP-specific phosphodiesterase 9A mRNA in the rat brain. J Neurosci. 2001;21:9068\u201376.","journal-title":"J Neurosci"},{"issue":"11","key":"11_CR5","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.2337\/diab.33.11.1090","volume":"33","author":"RN Auer","year":"1984","unstructured":"Auer RN, Olsson Y, Siesj\u00f6 BK. Hypoglycemic brain injury in the rat. Correlation of density of brain damage with the EEG isoelectric time: a quantitative study. Diabetes. 1984;33(11):1090\u20138.","journal-title":"Diabetes"},{"key":"11_CR6","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1523\/JNEUROSCI.3920-03.2004","volume":"24","author":"ZC Baquet","year":"2004","unstructured":"Baquet ZC, Gorski JA, Jones KR. Early striatal dendrite deficits fol- lowed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor. J Neurosci. 2004;24:4250\u20138.","journal-title":"J Neurosci"},{"key":"11_CR7","doi-asserted-by":"crossref","first-page":"E203","DOI":"10.1038\/ncb0802-e203","volume":"4","author":"AL Bauman","year":"2002","unstructured":"Bauman AL, Scott JD. Kinase- and phosphatase- anchoring proteins: harnessing the dynamic duo. Nat Cell Biol. 2002;4:E203.","journal-title":"Nat Cell Biol"},{"key":"11_CR8","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0026-895X(25)09714-7","volume":"46","author":"JA Beavo","year":"1994","unstructured":"Beavo JA, Conti M, Heaslip RJ. Multiple cyclic nucleotide phosphodiesterases. Mol Pharmacol. 1994;46:399\u2013405.","journal-title":"Mol Pharmacol"},{"key":"11_CR9","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1124\/pr.58.3.5","volume":"58","author":"AT Bender","year":"2006","unstructured":"Bender AT, Beavo JA. Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev. 2006;58:488\u2013520.","journal-title":"Pharmacol Rev"},{"key":"11_CR10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0197-4580(02)00015-5","volume":"24","author":"HA Bimonte","year":"2003","unstructured":"Bimonte HA, Nelson ME, Granholm AC. Age-related deficits as working memory load increases: relationships with growth factors. Neurobiol Aging. 2003;24:37\u201348.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"11_CR11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0166-2236(96)81862-5","volume":"19","author":"P Calabresi","year":"1996","unstructured":"Calabresi P, Pisani A, Mercuri NB, Bernardi G. The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia. Trends Neurosci. 1996;19(1):19\u201324.","journal-title":"Trends Neurosci"},{"key":"11_CR12","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S1474-4422(06)70600-7","volume":"5","author":"P Calabresi","year":"2006","unstructured":"Calabresi P, Picconi B, Parnetti L, Di Filippo M. A convergent model for cognitive dysfunctions in Parkinson\u2019s disease: the critical dopamine-acetylcholine synaptic balance. Lancet Neurol. 2006;5:974\u201383.","journal-title":"Lancet Neurol"},{"key":"11_CR13","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.neuint.2007.02.002","volume":"5","author":"M Chalimoniuk","year":"2007","unstructured":"Chalimoniuk M, Langfort J. The effect of subchronic, intermittent L-DOPA treatment on neuronal nitric oxide synthase and soluble guanylyl cyclase expression and activity in the striatum and midbrain of normal and MPTP-treated mice. Neurochem Int. 2007;5:821\u201333.","journal-title":"Neurochem Int"},{"key":"11_CR14","first-page":"647","volume":"56","author":"M Chalimoniuk","year":"2004","unstructured":"Chalimoniuk M, Stepien A. Influence of the therapy with pergolide mesylate plus L-DOPA and with L-DOPA alone on serum cGMP level in PD patients. Pol J Pharmacol. 2004;56:647\u201350.","journal-title":"Pol J Pharmacol"},{"key":"11_CR15","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.bbrc.2004.09.028","volume":"324","author":"M Chalimoniuk","year":"2004","unstructured":"Chalimoniuk M, Langfort J, Lukacova N, Marsala J. Upregulation of guanylyl cyclase expression and activity in striatum of MPTP-induced parkinsonism in mice. Biochem Biophys Res Commun. 2004;324:118\u201326.","journal-title":"Biochem Biophys Res Commun"},{"key":"11_CR16","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/(SICI)1096-9861(19990503)407:2<287::AID-CNE9>3.0.CO;2-R","volume":"407","author":"JA Cherry","year":"1999","unstructured":"Cherry JA, Davis RL. Cyclic AMP phospho- diesterases are localized in regions of the mouse brain associated with reinforcement, movement, and affect. J Comp Neurol. 1999;407:287\u2013301.","journal-title":"J Comp Neurol"},{"issue":"6","key":"11_CR17","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1046\/j.1460-9568.2002.01938.x","volume":"15","author":"F Cicchetti","year":"2002","unstructured":"Cicchetti F, Brownell AL, Williams K, Chen YI, Livni E, Isacson O. Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging. Eur J Neurosci. 2002;15(6):991\u20138.","journal-title":"Eur J Neurosci"},{"key":"11_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0079-6603(08)60718-7","volume":"63","author":"M Conti","year":"1999","unstructured":"Conti M, Jin SL. The molecular biology of cyclic nucleotide phosphodiesterases. Prog Nucleic Acid Res Mol Biol. 1999;63:1\u201338.","journal-title":"Prog Nucleic Acid Res Mol Biol"},{"key":"11_CR19","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1046\/j.1432-1327.2000.01297.x","volume":"267","author":"JD Corbin","year":"2000","unstructured":"Corbin JD, Turko IV, Beasley A, Francis SH. Phosphorylation of phosphodiesterase-5 by cyclic nucleotide-dependent protein kinase alters its catalytic and allosteric cGMP-binding activities. Eur J Biochem. 2000;267:2760\u20137.","journal-title":"Eur J Biochem"},{"key":"11_CR20","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1369\/jhc.6A6930.2006","volume":"54","author":"TM Coskran","year":"2006","unstructured":"Coskran TM, Morton D, Menniti FS, Adamowicz WO, Kleiman RJ, Ryan AM, et al. Immunohistochemical localization of phosphodiesterase 10A in multiple mammalian species. J Histochem Cytochem. 2006;54:1205\u201313.","journal-title":"J Histochem Cytochem"},{"key":"11_CR21","doi-asserted-by":"crossref","first-page":"12944","DOI":"10.1074\/jbc.M404706200","volume":"280","author":"A Das","year":"2005","unstructured":"Das A, Xi L, Kukreja RC. Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis: essential role of nitric oxide signaling. J Biol Chem. 2005;280:12944\u201355.","journal-title":"J Biol Chem"},{"issue":"1\u20132","key":"11_CR22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neulet.2006.03.061","volume":"402","author":"Z March De","year":"2006","unstructured":"De March Z, Giamp\u00e0 C, Patassini S, Bernardi G, Fusco FR. Cellular localization of TRPC5 in the substantia nigra of rat. Neurosci Lett. 2006;402(1\u20132):35\u20139.","journal-title":"Neurosci Lett"},{"issue":"3","key":"11_CR23","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.nbd.2008.02.010","volume":"30","author":"Z March De","year":"2008","unstructured":"De March Z, Giamp\u00e0 C, Patassini S, Bernardi G, Fusco FR. Beneficial effects of rolipram in the R6\/2 mouse model of Huntington's disease. Neurobiol Dis. 2008;30(3):375\u201387.","journal-title":"Neurobiol Dis"},{"key":"11_CR24","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","volume":"27","author":"M Figlia Di","year":"1997","unstructured":"Di Figlia M, Sapp E, Chase KO, et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science. 1997;27:1990\u20133.","journal-title":"Science"},{"issue":"47","key":"11_CR25","doi-asserted-by":"crossref","first-page":"16513","DOI":"10.1073\/pnas.0405973101","volume":"101","author":"LM DiPilato","year":"2004","unstructured":"DiPilato LM, Cheng X, Zhang J. Fluorescent indicators of cAMP and Epac activation reveal differential dynamics of cAMP signaling within discrete subcellular compartments. Proc Natl Acad Sci U S A. 2004;101(47):16513\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"11_CR26","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1073\/pnas.0536856100","volume":"100","author":"W Duan","year":"2003","unstructured":"Duan W, Guo Z, Jiang H, et al. Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progres- sion, and increases survival in huntingtin mutant mice. Proc Natl Acad Sci U S A. 2003;100(5):2911\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11_CR27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0006-8993(00)02237-X","volume":"866","author":"I Ferrer","year":"2000","unstructured":"Ferrer I, Goutan E, Marin C, Rey MJ, Ribalta T. Brain-derived neurotrophic factor in Huntington disease. Brain Res. 2000;866:257\u201361.","journal-title":"Brain Res"},{"key":"11_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0079-6603(00)65001-8","volume":"65","author":"SH Francis","year":"2000","unstructured":"Francis SH, Turko IV, Corbin JD. Cyclic nucleotide phosphodiesterases: relating structure and function. Prog Nucl Acid Res Mol Biol. 2000;65:1\u201352.","journal-title":"Prog Nucl Acid Res Mol Biol"},{"key":"11_CR29","doi-asserted-by":"crossref","first-page":"18438","DOI":"10.1074\/jbc.274.26.18438","volume":"274","author":"K Fujishige","year":"1999","unstructured":"Fujishige K, Kotera J, Michibata H, Yuasa K, Takebayashi S, Okumura K, Omori K. Cloning and characterization of a novel human phosphodiesterase that hydrolyzes both cAMP and cGMP (PDE10A). J Biol Chem. 1999;274:18438\u201345.","journal-title":"J Biol Chem"},{"issue":"3","key":"11_CR30","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2174\/1381612820666140826113957","volume":"21","author":"FR Fusco","year":"2015","unstructured":"Fusco FR, Giamp\u00e0 C. Phosphodiesterases as therapeutic targets for Huntington's disease. Curr Pharm Des. 2015;21(3):365\u201377.","journal-title":"Curr Pharm Des"},{"issue":"4","key":"11_CR31","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1523\/JNEUROSCI.19-04-01189.1999","volume":"19","author":"FR Fusco","year":"1999","unstructured":"Fusco FR, Chen Q, Lamoreaux WJ, Figueredo-Cardenas G, Jiao Y, Coffman JA, et al. Cellular localization of huntingtin in striatal and cortical neurons in rats: lack of correlation with neuronal vulnerability in Huntington's disease. J Neurosci. 1999;19(4):1189\u2013202.","journal-title":"J Neurosci"},{"issue":"5","key":"11_CR32","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1046\/j.1460-9568.2003.02844.x","volume":"18","author":"FR Fusco","year":"2003","unstructured":"Fusco FR, Zuccato C, Tartari M, Martorana A, De March Z, Giamp\u00e0 C, et al. Co-localization of brain-derived neurotrophic factor (BDNF) and wild-type huntingtin in normal and quinolinic acid-lesioned rat brain. Eur J Neurosci. 2003;18(5):1093\u2013102.","journal-title":"Eur J Neurosci"},{"issue":"1","key":"11_CR33","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.nbd.2012.01.011","volume":"46","author":"FR Fusco","year":"2012","unstructured":"Fusco FR, Anzilotti S, Giamp\u00e0 C, Dato C, Laurenti D, Leuti A, et al. Changes in the expression of extracellular regulated kinase (ERK 1\/2) in the R6\/2 mouse model of Huntington's disease after phosphodiesterase IV inhibition. Neurobiol Dis. 2012;46(1):225\u201333.","journal-title":"Neurobiol Dis"},{"key":"11_CR34","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1471-4159.2007.05137.x","volume":"105","author":"K Gharami","year":"2008","unstructured":"Gharami K, Xie Y, An JJ, Tonegawa S, Xu B. Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington's disease phenotypes in mice. J Neurochem. 2008;105:369\u201379.","journal-title":"J Neurochem"},{"issue":"1","key":"11_CR35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1460-9568.2005.04545.x","volume":"23","author":"C Giamp\u00e0","year":"2006","unstructured":"Giamp\u00e0 C, DeMarch Z, D'Angelo V, Morello M, Martorana A, Sancesario G, et al. Striatal modulation of cAMP-response-element-binding protein (CREB) after excitotoxic lesions: implications with neuronal vulnerability in Huntington's disease. Eur J Neurosci. 2006;23(1):11\u201320.","journal-title":"Eur J Neurosci"},{"issue":"3","key":"11_CR36","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.neulet.2007.07.049","volume":"424","author":"C Giamp\u00e0","year":"2007","unstructured":"Giamp\u00e0 C, DeMarch Z, Patassini S, Bernardi G, Fusco FR. Immunohistochemical localization of TRPC6 in the rat substantia nigra. Neurosci Lett. 2007;424(3):170\u20134.","journal-title":"Neurosci Lett"},{"issue":"5","key":"11_CR37","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/j.1460-9568.2009.06649.x","volume":"29","author":"C Giamp\u00e0","year":"2009","unstructured":"Giamp\u00e0 C, Middei S, Patassini S, Borreca A, Marullo F, Laurenti D, et al. Phosphodiesterase type IV inhibition prevents sequestration of CREB binding protein, protects striatal parvalbumin interneurons and rescues motor deficits in the R6\/2 mouse model of Huntington's disease. Eur J Neurosci. 2009;29(5):902\u201310.","journal-title":"Eur J Neurosci"},{"issue":"10","key":"11_CR38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013417","volume":"5","author":"C Giamp\u00e0","year":"2010","unstructured":"Giamp\u00e0 C, Laurenti D, Anzilotti S, Bernardi G, Menniti FS, Fusco FR. Inhibition of the striatal specific phosphodiesterase PDE10A ameliorates striatal and cortical pathology in R6\/2 mouse model of Huntington's disease. PLoS One. 2010;5(10):e13417.","journal-title":"PLoS One"},{"key":"11_CR39","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/hmg\/ddg046","volume":"12","author":"S Gines","year":"2003","unstructured":"Gines S, Seong IS, Fossale E, Ivanova E, Trettel F, Gusella JF, Wheeler VC, Persichetti F, MacDonald ME. Specific progressive cAMP reduction implicates energy deficit in presympto- matic Huntington\u2019s disease knock-in mice. Hum Mol Genet. 2003;12:497\u2013508.","journal-title":"Hum Mol Genet"},{"key":"11_CR40","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1460-9568.2008.06387.x","volume":"28","author":"M Giorgi","year":"2008","unstructured":"Giorgi M, D\u2019Angelo V, Esposito Z, Nuccetelli V, Sorge R, Martorana A, et al. Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms. Eur J Neurosci. 2008;28:941\u201350.","journal-title":"Eur J Neurosci"},{"issue":"1","key":"11_CR41","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.nbd.2011.04.006","volume":"43","author":"M Giorgi","year":"2011","unstructured":"Giorgi M, Melchiorri G, Nuccetelli V, D'Angelo V, Martorana A, Sorge R, et al. PDE10A and PDE10A-dependent cAMP catabolism are dysregulated oppositely in striatum and nucleus accumbens after lesion of midbrain dopamine neurons in rat: a key step in parkinsonism physiopathology. Neurobiol Dis. 2011;43(1):293\u2013303.","journal-title":"Neurobiol Dis"},{"key":"11_CR42","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.cellsig.2004.12.017","volume":"17","author":"TA Goraya","year":"2005","unstructured":"Goraya TA, Cooper DM. Ca2+-calmodulin-dependent phosphodiesterase (PDE1): current perspectives. Cell Signal. 2005;17:789\u201397.","journal-title":"Cell Signal"},{"issue":"2","key":"11_CR43","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1124\/jpet.109.155994","volume":"331","author":"SM Grauer","year":"2009","unstructured":"Grauer SM, Pulito VL, Navarra RL, Kelly MP, Kelley C, Graf R, Langen B, Logue S, Brennan J, Jiang L, Charych E, Egerland U, Liu F, Marquis KL, Malamas M, Hage T, Comery TA, Brandon NJ. Phosphodiesterase 10A inhibitor activity in preclinical models of the positive, cognitive, and negative symptoms of schizophrenia. J Pharmacol Exp Ther. 2009;331(2):574\u201390.","journal-title":"J Pharmacol Exp Ther"},{"key":"11_CR44","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.expneurol.2012.10.020","volume":"239","author":"MA Gray","year":"2013","unstructured":"Gray MA, Egan GF, Ando A, Churchyard A, Chua P, Stout JC, Georgiou-Karistianis N. Prefrontal activity in Huntington's disease reflects cognitive and neuropsychiatric disturbances: the IMAGE-HD study. Exp Neurol. 2013;239:218\u201328.","journal-title":"Exp Neurol"},{"issue":"6","key":"11_CR45","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1073\/pnas.94.6.2693","volume":"94","author":"JF Guzowski","year":"1997","unstructured":"Guzowski JF, McGaugh JL. Antisense oligodeoxynucleotide-mediated disruption of hippocampal cAMP response element binding protein levels impairs consolidation of memory for water maze training. Proc Natl Acad Sci U S A. 1997;94(6):2693\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"11_CR46","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1124\/jpet.108.138586","volume":"326","author":"TB Halene","year":"2008","unstructured":"Halene TB, Siegel SJ. Antipsychotic-like properties of phosphodiesterase 4 inhibitors: evaluation of 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone (RO-20-1724) with auditory event-related potentials and prepulse inhibition of startle. J Pharmacol Exp Ther. 2008;326(1):230\u20139.","journal-title":"J Pharmacol Exp Ther"},{"key":"11_CR47","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.molmed.2009.01.003","volume":"15","author":"DP Hanger","year":"2009","unstructured":"Hanger DP, Anderton BH, Noble W. Tau phosphoryla- tion: the therapeutic challenge for neurodegenerative disease. Trends Mol Med. 2009;15:112\u20139.","journal-title":"Trends Mol Med"},{"key":"11_CR48","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1023\/A:1009257909785","volume":"11","author":"GE Hardingham","year":"1998","unstructured":"Hardingham GE, Bading H. Nuclear calcium: a key regulator of gene expression. Biometals. 1998;11:345\u201358.","journal-title":"Biometals"},{"key":"11_CR49","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.neuroscience.2003.11.009","volume":"123","author":"AL Hebb","year":"2004","unstructured":"Hebb AL, Robertson HA, Denovan-Wright EM. Striatal phosphodiesterase mRNA and protein levels are reduced in Huntington's disease transgenic mice prior to the onset of motor symptoms. Neuroscience. 2004;123:967\u201381.","journal-title":"Neuroscience"},{"issue":"6","key":"11_CR50","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1111\/j.1471-4159.2007.04657.x","volume":"102","author":"R Hepp","year":"2007","unstructured":"Hepp R, Tricoire L, Hu E, Gervasi N, Paupardin-Tritsch D, Lambolez B, Vincent P. Phosphodiesterase type 2 and the homeostasis of cyclic GMP in living thalamic neurons. J Neurochem. 2007;102(6):1875\u201386.","journal-title":"J Neurochem"},{"issue":"10","key":"11_CR51","volume":"7","author":"SL Hong","year":"2012","unstructured":"Hong SL, Cossyleon D, Hussain WA, Walker LJ, Barton SJ, Rebec GV. Dysfunctional behavioral modulation of corticostriatal communication in the R6\/2 mouse model of Huntington's disease. PLoS One. 2012;7(10):e47026.","journal-title":"PLoS One"},{"key":"11_CR52","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00702-002-0797-1","volume":"110","author":"R Hosoi","year":"2003","unstructured":"Hosoi R, Ishikawa M, Kobayashi K, Gee A, Yamaguchi M, Inoue O. Effect of rolipram on muscarinic acetylcholine receptor binding in the intact mouse brain. J Neural Transm. 2003;110:363\u201372.","journal-title":"J Neural Transm"},{"key":"11_CR53","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0022-3565(25)39507-8","volume":"267","author":"MA Hossain","year":"1993","unstructured":"Hossain MA, Weiner N. Dopaminergic functional supersensitivity: effect of L-dopa and carbidopa treatment in an animal model of Parkinson's disease. J Pharmacol Exp Ther. 1993;267:1105\u201311.","journal-title":"J Pharmacol Exp Ther"},{"key":"11_CR54","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0065-2571(94)00012-R","volume":"35","author":"MD Houslay","year":"1995","unstructured":"Houslay MD. Compartmentalization of cyclic AMP phosphodiesterases, signaling \u2018crosstalk\u2019, desensitization and the phosphorylation of Gi-2 add cell specific personalization to the control of the levels of the second messenger cyclic AMP. Advan Enzyme Regul. 1995;35:303\u201338.","journal-title":"Advan Enzyme Regul"},{"key":"11_CR55","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1006\/scdb.1997.0221","volume":"9","author":"MD Houslay","year":"1998","unstructured":"Houslay MD. Adaptation in cyclic AMP signalling processes: a central role for cyclic AMP phosphodiesterases. Semin Cell Dev Biol. 1998;9:161.","journal-title":"Semin Cell Dev Biol"},{"key":"11_CR56","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0079-6603(01)69049-4","volume":"6","author":"MD Houslay","year":"2001","unstructured":"Houslay MD. PDE4 cAMP-specific phosphodiesterases. Prog Nucleic Acid Res Mol Biol. 2001;6:249.","journal-title":"Prog Nucleic Acid Res Mol Biol"},{"key":"11_CR57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj20021698","volume":"370","author":"MD Houslay","year":"2003","unstructured":"Houslay MD, Adams DR. PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization. Biochem J. 2003;370:1\u201318.","journal-title":"Biochem J"},{"key":"11_CR58","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0968-0004(97)01050-5","volume":"22","author":"MD Houslay","year":"1997","unstructured":"Houslay MD, Milligan G. Tailoring cAMP- signalling responses through isoform multiplicity. Trends Biochem Sci. 1997;22:217\u201324.","journal-title":"Trends Biochem Sci"},{"issue":"12","key":"11_CR59","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1111\/j.1460-9568.2004.03796.x","volume":"20","author":"H Hu","year":"2004","unstructured":"Hu H, EA MC, Hebb AL, Gomez GT, Denovan-Wright EM. Mutant huntingtin affects the rate of transcription of striatum-specific isoforms of phosphodiesterase 10A. Eur J Neurosci. 2004;20(12):3351\u201363.","journal-title":"Eur J Neurosci"},{"key":"11_CR60","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejphar.2004.07.084","volume":"498","author":"T Itoh","year":"2004","unstructured":"Itoh T, Tokumura M, Abe K. Effects of rolipram, a phosphodies- terase 4 inhibitor, in combination with imipramine on depressive behavior, CRE-binding activity and BDNF level in learned helplessness rats. Eur J Pharmacol. 2004;498:135\u201342.","journal-title":"Eur J Pharmacol"},{"key":"11_CR61","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1093\/cercor\/bhp004","volume":"19","author":"D Jancic","year":"2009","unstructured":"Jancic D, Lopez de Armentia M, Valor LM, Olivares R, Barco A. Inhibition of cAMP response element-binding protein reduces neuronal excitability and plasticity, and triggers neurodegeneration. Cereb Cortex. 2009;19:2535\u201347.","journal-title":"Cereb Cortex"},{"key":"11_CR62","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1042\/BST0350931","volume":"35","author":"E Jarnaess","year":"2007","unstructured":"Jarnaess E, Tasken K. Spatiotemporal control of cAMP signalling processes by anchored signalling complexes. Biochem Soc Trans. 2007;35:931\u20137.","journal-title":"Biochem Soc Trans"},{"key":"11_CR63","doi-asserted-by":"crossref","first-page":"37\u221250","DOI":"10.1007\/BF00688122","volume":"67","author":"H Kalimo","year":"1985","unstructured":"Kalimo H, Auer RN, Siesjo BK. The temporal evolution of hypoglycemic brain damage. III. Light and electron microscopic findings in the rat caudato putamen. Acta Neuropathol. 1985;67:37\u221250.","journal-title":"Acta Neuropathol"},{"key":"11_CR64","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1046\/j.1471-4159.1999.0730129.x","volume":"73","author":"LA Kobierski","year":"1999","unstructured":"Kobierski LA, Wong AE, Srivastava S, Borsook D, Hyman SE. Cyclic AMP-dependent activation of the proenkephalin gene requires phosphory- lation of CREB at serine-133 and a Src-related kinase. J Neurochem. 1999;73:129\u201338.","journal-title":"J Neurochem"},{"key":"11_CR65","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.1523\/JNEUROSCI.14-09-05623.1994","volume":"14","author":"C Konradi","year":"1994","unstructured":"Konradi C, Cole RL, Heckers S, Hyman SE. Amphetamine regulates gene expression in rat striatum via transcription factor CREB. J Neurosci. 1994;14:5623\u201334.","journal-title":"J Neurosci"},{"key":"11_CR66","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1074\/jbc.M308471200","volume":"279","author":"J Kotera","year":"2004","unstructured":"Kotera J, Sasaki T, Kobayashi T, Fujishige K, Yamashita Y, Omori K. Subcellular localization of cyclic nucleotide phosphodiesterase type 10A variants, and alteration of the localization by cAMP-dependent protein kinase-dependent phosphorylation. J Biol Chem. 2004;279:4366\u201375.","journal-title":"J Biol Chem"},{"key":"11_CR67","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1146\/annurev.bi.48.070179.004423","volume":"48","author":"EG Krebs","year":"1979","unstructured":"Krebs EG, Beavo JA. Phosphorylation- dephosphorylation of enzymes. Annu Rev Biochem. 1979;48:923\u201359.","journal-title":"Annu Rev Biochem"},{"key":"11_CR68","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/ana.20259","volume":"56","author":"HT Lee","year":"2004","unstructured":"Lee HT, Chang YC, Wang LY, Wang ST, Huang CC, et al. cAMP response element-binding protein activation in ligation preconditioning in neonatal brain. Ann Neurol. 2004;56:611\u201323.","journal-title":"Ann Neurol"},{"key":"11_CR69","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.tips.2004.06.006","volume":"25","author":"RJ Lefkowitz","year":"2004","unstructured":"Lefkowitz RJ. Historical review: a brief history and personal retrospective of seven-transmembrane receptors. Trends Pharmacol Sci. 2004;25:413.","journal-title":"Trends Pharmacol Sci"},{"key":"11_CR70","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.nbd.2012.11.016","volume":"52","author":"A Leuti","year":"2013","unstructured":"Leuti A, Laurenti D, Giamp\u00e0 C, Montagna E, Dato C, Anzilotti S, Melone MA, Bernardi G, Fusco FR. Phosphodiesterase 10A (PDE10A) localization in the R6\/2 mouse model of Huntington's disease. Neurobiol Dis. 2013;52:104\u201316.","journal-title":"Neurobiol Dis"},{"key":"11_CR71","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0378-1119(99)00171-7","volume":"234","author":"K Loughney","year":"1999","unstructured":"Loughney K, Snyder PB, Uher L, Rosman GJ, Ferguson K, Florio VA. Isolation and characterization of PDE10A, a novel human 3\u2032, 5\u2032-cyclic nucleotide phosphodiesterase. Gene. 1999;234:109\u201311778.","journal-title":"Gene"},{"key":"11_CR72","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/hmg\/9.9.1259","volume":"9","author":"R Luthi-Carter","year":"2000","unstructured":"Luthi-Carter R, Strand A, Peters NL, Solano SM, Hollingsworth ZR, Menon AS, et al. Decreased expression of striatal signaling genes in a mouse model of Huntington\u2019s disease. Hum Mol Genet. 2000;9:1259\u201371.","journal-title":"Hum Mol Genet"},{"key":"11_CR73","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1002\/jnr.21788","volume":"86","author":"A Marte","year":"2008","unstructured":"Marte A, Pepicelli O, Cavallero A, Raiteri M, Fedele E. In vivo effects of phosphodiesterase inhibition on basal cyclic guanosine monophosphate levels in the prefrontal cortex, hippocampus and cerebellum of freely moving rats. J Neurosci Res. 2008;86:3338\u201347.","journal-title":"J Neurosci Res"},{"issue":"5","key":"11_CR74","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/ana.10728","volume":"54","author":"PL McGeer","year":"2003","unstructured":"McGeer PL, Schwab C, Parent A, Doudet D. Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration. Ann Neurol. 2003;54(5):599\u2013604.","journal-title":"Ann Neurol"},{"issue":"2","key":"11_CR75","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1006\/exnr.2000.7530","volume":"166","author":"CA Meade","year":"2000","unstructured":"Meade CA, Figueredo-Cardenas G, Fusco F, Nowak TS Jr, Pulsinelli WA, Reiner A. Transient global ischemia in rats yields striatal projection neuron and interneuron loss resembling that in Huntington's disease. Exp Neurol. 2000;166(2):307\u201323.","journal-title":"Exp Neurol"},{"key":"11_CR76","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nrd2058","volume":"8","author":"FS Menniti","year":"2006","unstructured":"Menniti FS, Faraci WS, Schmidt CJ. Phosphodiesterases in the CNS: targets for drug development. Nat Rev Drug Discov. 2006;8:660\u201370.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"11_CR77","first-page":"54","volume":"8","author":"FS Menniti","year":"2007","unstructured":"Menniti FS, Chappie TA, Humphrey JM, Schmidt CJ. Phosphodiesterase 10A inhibitors: a novel approach to the treatment of the symptoms of schizophrenia. Curr Opin Investig Drugs. 2007;8(1):54\u20139. Review","journal-title":"Curr Opin Investig Drugs"},{"key":"11_CR78","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.278.5335.58","volume":"278","author":"EJ Nestler","year":"1997","unstructured":"Nestler EJ, Aghajanian GK. Molecular and cellular basis of addiction. Science. 1997;278:58\u201363.","journal-title":"Science"},{"issue":"42","key":"11_CR79","doi-asserted-by":"crossref","first-page":"10,460","DOI":"10.1523\/JNEUROSCI.2518-08.2008","volume":"28","author":"A Nishi","year":"2008","unstructured":"Nishi A, Kuroiwa M, Miller DB, O'Callaghan JP, Bateup HS, Shuto T, Sotogaku N, Fukuda T, Heintz N, Greengard P, Snyder GL. Distinct roles of PDE4 and PDE10A in the regulation of cAMP\/PKA signaling in the striatum. J Neurosci. 2008;28(42):10,460\u201371.","journal-title":"J Neurosci"},{"key":"11_CR80","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1515\/REVNEURO.1993.4.2.213","volume":"4","author":"N Nishino","year":"1993","unstructured":"Nishino N, Kitamura N, Hashimoto T, Tanaka C. Transmembrane signal- ling systems in the brain of patients with Parkinson's disease. Rev Neurosci. 1993;4:213\u201322.","journal-title":"Rev Neurosci"},{"key":"11_CR81","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1126\/science.1056784","volume":"291","author":"FC Nucifora Jr","year":"2001","unstructured":"Nucifora FC Jr, Sasaki M, Peters MF, Huang H, Cooper JK, et al. Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science. 2001;291:2423\u20138.","journal-title":"Science"},{"key":"11_CR82","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S1474-4422(06)70521-X","volume":"5","author":"CW Olanow","year":"2006","unstructured":"Olanow CW, Obeso JA, Stocchi F. Continuous dopamine-receptor treatment of Parkinson\u2019s disease: scientific rationale and clinical implications. Lancet Neurol. 2006;5:677\u201387.","journal-title":"Lancet Neurol"},{"issue":"Pt 11","key":"11_CR83","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1093\/brain\/awh625","volume":"128","author":"CF Orr","year":"2005","unstructured":"Orr CF, Rowe DB, Mizuno Y, Mori H, Halliday GM. A possible role for humoral immunity in the pathogenesis of Parkinson's disease. Brain. 2005;128(Pt 11):2665\u201374.","journal-title":"Brain"},{"issue":"14","key":"11_CR84","doi-asserted-by":"crossref","first-page":"5781","DOI":"10.1523\/JNEUROSCI.1238-14.2015","volume":"35","author":"FE Padovan-Neto","year":"2015","unstructured":"Padovan-Neto FE, Sammut S, Chakroborty S, Dec AM, Threlfell S, Campbell PW, Mudrakola V, Harms JF, Schmidt CJ, West AR. Facilitation of corticostriatal transmission following pharmacological inhibition of striatal phosphodiesterase 10A: role of nitric oxide-soluble guanylyl cyclase-cGMP signaling pathways. J Neurosci. 2015 Apr 8;35(14):5781\u201391.","journal-title":"J Neurosci"},{"key":"11_CR85","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1101\/lm.2213711","volume":"18","author":"F Papaleo","year":"2011","unstructured":"Papaleo F, Silverman JL, Aney J, Tian Q, Barkan CL, Chadman KK, Crawley JN. Working memory deficits, increased anxiety-like traits, and seizure susceptibility in BDNF overexpressing mice. Learn Mem. 2011;18:534\u201344.","journal-title":"Learn Mem"},{"key":"11_CR86","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nn1040","volume":"6","author":"B Picconi","year":"2003","unstructured":"Picconi B, Centonze D, Hakansson K, Bernardi G, Greengard P, Fisone G, et al. Loss of bidirectional striatal synaptic plasticity in L-dopa-induced dyskinesia. Nat Neurosci. 2003;6:501\u20136.","journal-title":"Nat Neurosci"},{"key":"11_CR87","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1523\/JNEUROSCI.14-03-01251.1994","volume":"14","author":"JW Polli","year":"1994","unstructured":"Polli JW, Kincaid RL. Expression of a calmodulin-dependent phosphodiesterase isoform (PDE1B1) correlates with brain regions having extensive dopaminergic innervation. J Neurosci. 1994;14:1251\u20136.","journal-title":"J Neurosci"},{"issue":"3","key":"11_CR88","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1471-4159.2008.05825.x","volume":"108","author":"E Puerta","year":"2009","unstructured":"Puerta E, Hervias I, Go\u00f1i-Allo B, Lasheras B, Jordan J, Aguirre N. Phosphodiesterase 5 inhibitors prevent 3,4-methylenedioxymethamphetamine-induced 5-HT deficits in the rat. J Neurochem. 2009;108(3):755\u201366.","journal-title":"J Neurochem"},{"issue":"2","key":"11_CR89","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.nbd.2010.01.013","volume":"38","author":"E Puerta","year":"2010","unstructured":"Puerta E, Hervias I, Barros-Mi\u00f1ones L, Jordan J, Ricobaraza A, Cuadrado-Tejedor M, et al. Sildenafil protects against 3-nitropropionic acid neurotoxicity through the modulation of calpain, CREB, and BDNF. Neurobiol Dis. 2010;38(2):237\u201345.","journal-title":"Neurobiol Dis"},{"key":"11_CR90","doi-asserted-by":"crossref","first-page":"6887","DOI":"10.1523\/JNEUROSCI.5291-04.2005","volume":"25","author":"D Puzzo","year":"2005","unstructured":"Puzzo D, Vitolo O, Trinchese F, Jacob JP, Palmeri A, Arancio O. Amyloid-beta peptide inhibits activation of the nitric oxide\/cGMP\/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity. J Neurosci. 2005;25:6887\u201397.","journal-title":"J Neurosci"},{"key":"11_CR91","doi-asserted-by":"crossref","first-page":"5188","DOI":"10.1523\/JNEUROSCI.22-12-05188.2002","volume":"22","author":"TM Reed","year":"2002","unstructured":"Reed TM, Repaske DR, Snyder GL, Greengard P, Vorhees CV. Phosphodiesterase 1B knock-out mice exhibit exaggerated locomotor hyperactivity and DARPP-32 phosphorylation in response to dopamine agonists and display impaired spatial learning. J Neurosci. 2002;22:5188\u201397.","journal-title":"J Neurosci"},{"key":"11_CR92","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0306-4522(93)90364-L","volume":"56","author":"DR Repaske","year":"1993","unstructured":"Repaske DR, Corbin JG, Conti M, Goy MF. A cyclic GMP-stimulated cyclic nucleotide phosphodiesterase gene is highly expressed in the limbic system of the rat brain. Neuroscience. 1993;56:673\u201386.","journal-title":"Neuroscience"},{"key":"11_CR93","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.neuroscience.2005.01.050","volume":"132","author":"E Reyes-Irisarri","year":"2005","unstructured":"Reyes-Irisarri E, Perez S, Mengod G. Neuronal expression of cAMP-specific phosphodiesterase 7B in the rat brain. Neuroscience. 2005;132:1173\u201385.","journal-title":"Neuroscience"},{"key":"11_CR94","doi-asserted-by":"crossref","unstructured":"Reyes-Irisarri E, Markerink-Van Ittersum M, Mengod G, de Vente J. Expression of the cGMP-specific phosphodiesterases 2 and 9 in normal and Alzheimer's disease human brains. Eur J Neurosci. 2007;25:3332\u20138.","DOI":"10.1111\/j.1460-9568.2007.05589.x"},{"key":"11_CR95","first-page":"467","volume":"224","author":"CSA Rubin","year":"1994","unstructured":"Rubin CSA. Kinase anchor proteins and the intracellular targeting of signals carried by cAMP. Biochim. Biophys Acta. 1994;224:467\u201379.","journal-title":"Biophys Acta"},{"key":"11_CR97","doi-asserted-by":"crossref","first-page":"17636","DOI":"10.1073\/pnas.1420162111","volume":"111","author":"Y Sagi","year":"2014","unstructured":"Sagi Y, Heiman M, Peterson JD, Musatov S, Kaplitt MG, Surmeier DJ, Heintz N, Greengard P. Nitric oxide regulates synaptic transmission between spiny projection neurons. Proc Natl Acad Sci U S A. 2014;111:17636\u201341.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"11_CR98","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1601-183X.2012.00858.x","volume":"12","author":"P Samadi","year":"2013","unstructured":"Samadi P, Boutet A, Rymar VV, Rawal K, Maheux J, Kvann JC, et al. Relationship between BDNF expression in major striatal afferents, striatum morphology and motor behavior in the R6\/2 mouse model of Huntington's disease. Genes Brain Behav. 2013;12(1):108\u201324.","journal-title":"Genes Brain Behav"},{"issue":"4","key":"11_CR99","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nchembio.799","volume":"8","author":"DPLM Sample","year":"2012","unstructured":"Sample DPLM, Yang JH. Ni Q, Saucerman JJ, Zhang J. Regulation of nuclear PKA revealed by spatiotemporal manipulation of cyclic AMP. Nat Chem Biol. 2012;8(4):375\u201382.","journal-title":"Nat Chem Biol"},{"key":"11_CR100","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/j.1460-9568.2004.03566.x","volume":"20","author":"G Sancesario","year":"2004","unstructured":"Sancesario G, Giorgi M, D'Angelo V, Modica A, Martorana A, Morello M, et al. Down-regulation of nitrergic transmission in the rat striatum after chronic nigrostriatal deafferentation. Eur J Neurosci. 2004;20:989\u20131000.","journal-title":"Eur J Neurosci"},{"issue":"3","key":"11_CR101","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1177\/1073858410384740. Epub 2011 Apr 15. Review.","volume":"17","author":"JL Sanderson","year":"2011","unstructured":"Sanderson JL, Dell'Acqua MLAKAP. Signaling complexes in regulation of excitatory synaptic plasticity. Neuroscientist. 2011;17(3):321\u201336. doi: 10.1177\/1073858410384740 . Epub 2011 Apr 15. Review.","journal-title":"Neuroscientist"},{"key":"11_CR102","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1471-4159.2007.05152.x","volume":"105","author":"H Sano","year":"2008","unstructured":"Sano H, Nagai Y, Miyakawa T, Shigemoto R, Yokoi M. Increased social interaction in mice deficient of the striatal medium spiny neuron-specific phos- phodiesterase 10A2. J Neurochem. 2008;105:546\u201356.","journal-title":"J Neurochem"},{"key":"11_CR103","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1042\/bj3610211","volume":"361","author":"T Sasaki","year":"2002","unstructured":"Sasaki T, Kotera J, Omori K. Novel alternative splice variants of rat phosphodiesterase 7B showing unique tissue-specific expression and phosphorylation. Biochem J. 2002;361:211\u201320.","journal-title":"Biochem J"},{"key":"11_CR104","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1124\/jpet.107.132910","volume":"325","author":"CJ Schmidt","year":"2008","unstructured":"Schmidt CJ, Chapin DS, Cianfrogna J, Corman ML, Hajos M, et al. Preclinical characterization of selective phosphodiesterase 10A inhibitors: a new therapeutic approach to the treatment of schizophrenia. J Pharmacol Exp Ther. 2008;325:681\u201390.","journal-title":"J Pharmacol Exp Ther"},{"key":"11_CR105","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0006-8993(03)02754-9","volume":"985","author":"TF Seeger","year":"2003","unstructured":"Seeger TF, Bartlett B, Coskran TM, Culp JS, James LC, Krull DL, Lanfear J, Ryan AM, Schmidt CJ, Strick CA, et al. Immunohistochemical localization of PDE10A in the rat brain. Brain Res. 2003;985:113\u201326.","journal-title":"Brain Res"},{"key":"11_CR106","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1152\/physrev.00001.2005","volume":"85","author":"S Seino","year":"2005","unstructured":"Seino S, Shibasaki T. PKA-dependent and PKA-independent pathways for cAMP-regulated exocytosis. Physiol Rev. 2005;85:1303\u201342.","journal-title":"Physiol Rev"},{"key":"11_CR107","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0079-6603(00)66031-2","volume":"66","author":"Y Shakur","year":"2001","unstructured":"Shakur Y, Holst LS, Landstrom TR, Movsesian M, Degerman E, Manganiello V. Regulation and function of the cyclic nucleotide phosphodiesterase (PDE3) gene family. Prog Nucleic Acid Res Mol Biol. 2001;66:241\u201377.","journal-title":"Prog Nucleic Acid Res Mol Biol"},{"key":"11_CR108","doi-asserted-by":"crossref","first-page":"14639","DOI":"10.1074\/jbc.M110.204453","volume":"286","author":"J Shi","year":"2011","unstructured":"Shi J, Qian W, Yin X, Iqbal K, Grundke-Iqbal I, et al. Cyclic AMP-dependent protein kinase regulates the alternative splicing of tau exon 10: a mechanism involved in tau pathology of Alzheimer disease. J Biol Chem. 2011;286:14639\u201348.","journal-title":"J Biol Chem"},{"issue":"2","key":"11_CR109","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.neuropharm.2006.01.012","volume":"51","author":"JA Siuciak","year":"2006","unstructured":"Siuciak JA, McCarthy SA, Chapin DS, Fujiwara RA, James LC, et al. Genetic deletion of the striatum-enriched phosphodiesterase PDE10A: evidence for altered striatal function. Neuropharmacology. 2006a;51(2):374\u201385.","journal-title":"Neuropharmacology"},{"issue":"2","key":"11_CR110","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.neuropharm.2006.04.013","volume":"51","author":"JA Siuciak","year":"2006","unstructured":"Siuciak JA, Chapin DS, Harms JF, Lebel LA, McCarthy SA, Chambers L, Shrikhande A, Wong S, Menniti FS, Schmidt CJ. Inhibition of the striatum-enriched phosphodiesterase PDE10A: a novel approach to the treatment of psychosis. Neuropharmacology. 2006b;51(2):386\u201396.","journal-title":"Neuropharmacology"},{"issue":"3","key":"11_CR111","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00213-007-0727-x","volume":"192","author":"JA Siuciak","year":"2007","unstructured":"Siuciak JA, Chapin DS, McCarthy SA, Martin AN. Antipsychotic profile of rolipram: efficacy in rats and reduced sensitivity in mice deficient in the phosphodiesterase-4B (PDE4B) enzyme. Psychopharmacology. 2007;192(3):415\u201324.","journal-title":"Psychopharmacology"},{"key":"11_CR112","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00213-007-1014-6","volume":"197","author":"JA Siuciak","year":"2008","unstructured":"Siuciak JA, McCarthy SA, Chapin DS, Martin AN. Behavioral and neurochemical characterization of mice deficient in the phosphodiesterase-4B (PDE4B) enzyme. Psychopharmacology. 2008;197:115\u201326.","journal-title":"Psychopharmacology"},{"issue":"4","key":"11_CR113","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/BF00690397","volume":"64","author":"ML Smith","year":"1984","unstructured":"Smith ML, Auer RN, Siesj\u00f6 BK. The density and distribution of ischemic brain injury in the rat following 2-10 min of forebrain ischemia. Acta Neuropathol. 1984;64(4):319\u201332.","journal-title":"Acta Neuropathol"},{"key":"11_CR114","doi-asserted-by":"crossref","first-page":"7071","DOI":"10.1073\/pnas.96.12.7071","volume":"96","author":"SH Soderling","year":"1999","unstructured":"Soderling SH, Bayuga SJ, Beavo JA. Isolation and characterization of a dual-substrate phosphodiesterase gene family: PDE10A. Proc Natl Acad Sci U S A. 1999;96:7071\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11_CR115","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1073\/pnas.100110097","volume":"97","author":"JS Steffan","year":"2000","unstructured":"Steffan JS, Kazantsev A, Spasic-Boskovic O, Greenwald M, Zhu YZ, Gohler H, et al. The Huntington\u2019s disease protein interacts with p53 and CREB- binding protein and represses transcription. Proc Natl Acad Sci U S A. 2000;97:6763\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11_CR116","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/294366a0","volume":"294","author":"JC Stoof","year":"1981","unstructured":"Stoof JC, Kebabian JW. Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum. Nature. 1981;294:366\u20138.","journal-title":"Nature"},{"issue":"2","key":"11_CR117","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.neuropharm.2009.09.008","volume":"58","author":"CA Strick","year":"2010","unstructured":"Strick CA, James LC, Fox CB, Seeger TF, Menniti FS, Schmidt CJ. Alterations in gene regulation following inhibition of the striatum-enriched phosphodiesterase, PDE10A. Neuropharmacology. 2010;58(2):444\u20135.","journal-title":"Neuropharmacology"},{"issue":"6","key":"11_CR118","doi-asserted-by":"crossref","first-page":"4988","DOI":"10.1074\/jbc.M310226200","volume":"279","author":"KL Sugars","year":"2004","unstructured":"Sugars KL, Brown R, Cook LJ, Swartz J, Rubinsztein DC. Decreased cAMP response element-mediated transcription: an early event in exon 1 and full-length cell models of Huntington's disease that contributes to polyglutamine pathogenesis. J Biol Chem. 2004;279(6):4988\u201399.","journal-title":"J Biol Chem"},{"key":"11_CR119","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1046\/j.1471-4159.1997.69051920.x","volume":"69","author":"CC Tenn","year":"1997","unstructured":"Tenn CC, Niles LP. Sensitization of G protein-coupled benzodiazepine receptors in the striatum of 6-hydroxydopamine-lesioned rats. J Neurochem. 1997;69:1920\u20136.","journal-title":"J Neurochem"},{"issue":"3","key":"11_CR120","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1124\/jpet.108.146332","volume":"328","author":"S Threlfell","year":"2009","unstructured":"Threlfell S, Sammut S, Menniti FS, Schmidt CJ, West AR. Inhibition of phosphodiesterase 10A increases the responsiveness of striatal projection neurons to cortical stimulation. J Pharmacol Exp Ther. 2009;328(3):785\u201395.","journal-title":"J Pharmacol Exp Ther"},{"key":"11_CR121","volume":"6","author":"KY Tseng","year":"2011","unstructured":"Tseng KY, Caballero A, Dec A, Cass DK, Simak N, Sunu E, Park MJ, Blume SR, Sammut S, Park DJ, West AR. Inhibition of striatal soluble guanylyl cyclase-cGMP signaling reverses basal ganglia dysfunction and akinesia in experimental parkinsonism. PLoS One. 2011;6:e27187.","journal-title":"PLoS One"},{"issue":"2\u20133","key":"11_CR122","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.pscychresns.2012.01.002","volume":"203","author":"PG Unschuld","year":"2012","unstructured":"Unschuld PG, Joel SE, Pekar JJ, Reading SA, Oishi K, McEntee J. Depressive symptoms in prodromal Huntington's disease correlate with Stroop-interference related functional connectivity in the ventromedial prefrontal cortex. Psychiatry Res. 2012;203(2\u20133):166\u201374.","journal-title":"Psychiatry Res"},{"key":"11_CR123","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2826.1994.tb00623.x","volume":"6","author":"M Vallejo","year":"1994","unstructured":"Vallejo M. Transcriptional control of gene expression by cAMP-response element binding proteins. J Neuroendocrinol. 1994;6:587\u201396.","journal-title":"J Neuroendocrinol"},{"key":"11_CR124","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0006-8993(00)03081-X","volume":"888","author":"WCG Staveren Van","year":"2001","unstructured":"Van Staveren WCG, Markerink-van Ittersum M, Steinbusch HWM, de Vente J. The effects of phosphodiesterase inhibition on cyclic GMP and cyclic AMP accumulation in the hippocampus of the rat. Brain Res. 2001;888:275\u201386.","journal-title":"Brain Res"},{"issue":"8\u20139","key":"11_CR125","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1023\/A:1025704031210","volume":"31","author":"WC Staveren Van","year":"2002","unstructured":"Van Staveren WC, Glick J, Markerink-van Ittersum M, Shimizu M, Beavo JA, Steinbusch HW, et al. Cloning and localization of the cGMP-specific phosphodiesterase type 9 in the rat brain. J Neurocytol. 2002;31(8\u20139):729\u201341.","journal-title":"J Neurocytol"},{"key":"11_CR126","doi-asserted-by":"crossref","unstructured":"Van Staveren WC, Steinbusch HW, Markerink-Van Ittersum M, Repaske DR, Goy MF, Kotera J, Omori K, et al. mRNA expression patterns of the cGMP-hydrolyzing phosphodiesterases types 2, 5, and 9 during development of the rat brain. J Comp Neurol. 2003;467:566\u201380.","DOI":"10.1002\/cne.10955"},{"key":"11_CR127","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1111\/j.0953-816X.2004.03327.x","volume":"19","author":"WC Staveren Van","year":"2004","unstructured":"Van Staveren WC, Steinbusch HW, Markerink-van Ittersum M, Behrends S, de Vente J. Species differences in the localization of cGMP-producing and NO-responsive elements in the mouse and rat hippocampus using cGMP immunocyto- chemistry. Eur J Neurosci. 2004;19:2155\u201368.","journal-title":"Eur J Neurosci"},{"key":"11_CR128","doi-asserted-by":"crossref","first-page":"13217","DOI":"10.1073\/pnas.172504199","volume":"99","author":"SA Vitolo","year":"2002","unstructured":"Vitolo SA, Costanzo V, Battaglia F, Arancio O, Shelanski M. Amyloid beta -peptide inhibition of the PKA\/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling. Proc Natl Acad Sci U S A. 2002;99:13217\u201321.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11_CR129","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/416535a","volume":"416","author":"DM Walsh","year":"2002","unstructured":"Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature. 2002;416:535\u20139.","journal-title":"Nature"},{"issue":"3","key":"11_CR130","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s11011-014-9533-4","volume":"29","author":"C Wang","year":"2014","unstructured":"Wang C, Zhang J, Lu Y, Lin P, Pan T, Zhao X, Liu A, Wang Q, Zhou W, Zhang HT. Antidepressant-like effects of the phosphodiesterase-4 inhibitor etazolate and phosphodiesterase-5 inhibitor sildenafil via cyclic AMP or cyclic GMP signaling in mice. Metab Brain Dis. 2014;29(3):673\u201382.","journal-title":"Metab Brain Dis"},{"key":"11_CR131","first-page":"9","volume":"91","author":"T Wichmann","year":"2003","unstructured":"Wichmann T, DeLong MR. Functional neuroanatomy of the basal gang- lia in Parkinson\u2019s disease. Adv Neurol. 2003;91:9\u201318.","journal-title":"Adv Neurol"},{"key":"11_CR132","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2012.17","volume":"2","author":"V Wiescholleck","year":"2012","unstructured":"Wiescholleck V, Manahan-Vaughan D. PDE4 inhibition enhances hippocampal synaptic plasticity in vivo and rescues MK801-induced impairment of long-term potentiation and object recognition memory in an animal model of psychosis. Transl Psychiatry. 2012;2:e89.","journal-title":"Transl Psychiatry"},{"key":"11_CR133","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/hmg\/10.17.1829","volume":"10","author":"A Wyttenbach","year":"2001","unstructured":"Wyttenbach A, Swartz J, Kita H, Thykjaer T, Carmichael J, Bradley J, et al. Polyglutamine expansions cause decreased CRE- mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington\u2019s disease. Hum Mol Genet. 2001;10:1829\u201345.","journal-title":"Hum Mol Genet"},{"key":"11_CR134","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.neuroscience.2005.12.042","volume":"139","author":"Z Xie","year":"2006","unstructured":"Xie Z, et al. Cellular and subcellular localization of PDE10A, a striatal-specific phosphodiesterase. Neuroscience. 2006;139:597\u2013607.","journal-title":"Neuroscience"},{"issue":"44","key":"11_CR136","doi-asserted-by":"crossref","first-page":"14708","DOI":"10.1523\/JNEUROSCI.1637-10.2010","volume":"30","author":"X Yuxiang","year":"2010","unstructured":"Yuxiang X, Hayden MR, Baoji X. BDNF overexpression in the forebrain rescues Huntington\u2019s disease phenotypes in YAC128 mice. J Neurosci. 2010;30(44):14708\u201318.","journal-title":"J Neurosci"},{"issue":"1","key":"11_CR137","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.1471-4159.2003.01980.x","volume":"87","author":"Y Zhang","year":"2003","unstructured":"Zhang Y, Li M, Drozda M, Chen M, Ren S, Mejia Sanchez RO, Leavitt BR, Cattaneo E, et al. Depletion of wild-type huntingtin in mouse models of neurologic diseases. J Neurochem. 2003;87(1):101\u20136.","journal-title":"J Neurochem"},{"key":"11_CR138","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neulet.2004.03.054","volume":"363","author":"G Zhu","year":"2004","unstructured":"Zhu G, Okada M, Yoshida S, Hirose S, Kaneko S. Pharmacological discrimination of protein kinase associated exocytosis mechanisms between dopamine and 3,4-dihydroxyphenylalanine in rat striatum using in vivo microdialysis. Neurosci Lett. 2004;363:120\u20134.","journal-title":"Neurosci Lett"},{"issue":"5\u20136","key":"11_CR139","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pneurobio.2007.01.003","volume":"81","author":"C Zuccato","year":"2007","unstructured":"Zuccato C, Cattaneo E. Role of brain-derived neurotrophic factor in Huntington's disease. Prog Neurobiol. 2007;81(5\u20136):294\u2013330.","journal-title":"Prog Neurobiol"},{"issue":"1","key":"11_CR140","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ng1219","volume":"35","author":"C Zuccato","year":"2003","unstructured":"Zuccato C, Tartari M, Crotti A, Goffredo D, Valenza M, Conti L, Cataudella T. Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat Genet. 2003;35(1):76\u201383.","journal-title":"Nat Genet"}],"container-title":["Advances in Neurobiology","Phosphodiesterases: CNS Functions and Diseases"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-58811-7_11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T22:35:48Z","timestamp":1750890948000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-58811-7_11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9783319588094","9783319588117"],"references-count":138,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-58811-7_11","relation":{},"ISSN":["2190-5215","2190-5223"],"issn-type":[{"value":"2190-5215","type":"print"},{"value":"2190-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}